RELEXXII: payments to doctors
Payments that named RELEXXII as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $224K
- Providers
- 6,697
- Transactions
- 11,186
- Average per transaction
- $20
The per-transaction average — $20 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,697 providers the average total is $33, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vertical Pharmaceuticals, LLC | $223,422 | 99.7% |
| Avion Pharmaceuticals | $592 | 0.3% |
| Acella Pharmaceuticals, LLC | $14 | 0.0% |